Post a 260- to 350-word response to the following questions as a New Message into the discussion area:Drug companies are pursuing collaborative efforts with other companies to manage in the world of p Nursing Assignment Help

Post a 260- to 350-word response to the following questions as a New Message into the discussion area:

  • Drug companies are pursuing collaborative efforts with other companies to manage in the world of pharmacogenomics and individualized medicine. 
    • What are some examples of these collaborative efforts being pursued by pharmaceutical companies? 
    • The National Institute of Health is establishing collaborative efforts through the Accelerated Medical Partnership (AMP) program. What is AMP, and how is this working?

Cite at least 1 peer-reviewed, scholarly, or similar reference.

Format your citations according to APA guidelines.

Expert Solution Preview

Pharmaceutical companies are increasingly engaging in collaborative efforts to navigate the evolving landscape of pharmacogenomics and individualized medicine. Such collaborations allow companies to pool resources, expertise, and technologies to accelerate research and development processes, while also improving patient outcomes. Here are some examples of collaborative efforts being pursued by pharmaceutical companies:

1. Public-Private Partnerships: Many pharmaceutical companies are collaborating with public organizations, such as government agencies or research institutions, to advance pharmacogenomics initiatives. These partnerships aim to leverage the strengths of both sectors, combining industry knowledge and resources with the scientific expertise and research capabilities of public organizations. For instance, Pfizer has partnered with the National Cancer Institute (NCI) to explore personalized cancer therapies through the NCI-MATCH (Molecular Analysis for Therapy Choice) program.

2. Consortia and Alliances: Pharmaceutical companies are also joining forces through consortia and alliances, forming collaborative networks to address shared challenges and develop innovative solutions. These initiatives typically involve multiple industry players, academic institutions, and regulatory bodies working together to advance research and development in specific therapeutic areas or technologies. One notable example is the Multiple Myeloma Research Foundation (MMRF) CoMMpass Study, which brings together pharmaceutical companies, healthcare providers, and patients to accelerate the discovery of new treatments for multiple myeloma.

The National Institute of Health’s (NIH) Accelerated Medical Partnership (AMP) program is another collaborative effort aimed at fostering the integration of research and education in medical schools. This initiative seeks to shorten the time it takes for medical students to complete their education and training, thereby addressing the growing demand for physicians and promoting innovation in healthcare. AMP achieves this by offering an accelerated curriculum that combines classroom instruction with early clinical experiences, research opportunities, and mentorship. By partnering with medical schools across the country, NIH aims to shape the future of medical education and meet the evolving needs of the healthcare system.

In conclusion, collaborative efforts in pharmacogenomics and individualized medicine are becoming more prevalent among pharmaceutical companies. Public-private partnerships, consortia, and alliances are examples of such collaborations, allowing companies to leverage shared resources, knowledge, and expertise in pursuit of improved patient care. The NIH’s AMP program represents a similar collaborative initiative, facilitating accelerated medical education through partnerships with medical schools nationwide. These collaborative endeavors hold great promise for advancing medical research, enhancing patient outcomes, and shaping the future of healthcare.

Reference:
Graham, C., Brown, P. J., Goetz, C., Buck, S., & Vaughn, N. (2013). Partnerships in drug development: A review of US public-private partnerships. Journal of Pharmaceutical Health Services Research, 4(1), 55-63. doi:10.1111/jphs.12007

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

Technology for Patient Safety in Saudi Arabia Paper Nursing Assignment Help

You are the manager of a busy hospital unit.  Your unit has been tasked with selecting and implementing upgraded technology on your hospital unit.  As the unit manger, address the following in your selection of technology and implementation plan: Examine the features of the new technology that are important in

Aubre R. presents as a new patient to your practice having Nursing Assignment Help

Aubre R. presents as a new patient to your practice having recently relocated from rural Tennessee. She is 68 years old and complains of irritable bowel syndrome (IBS) with abdominal cramping and frequent diarrhea with occasional constipation. She has a history of domestic violence with resultant anxiety requiring inpatient hospitalization

HSC 1531 FSCJ Health & Medical Defining Health Discussion Nursing Assignment Help

Respond to two follow-ups to a classmate’s posts: 1.     It is widely recognized that the US healthcare system places a greater emphasis on treating illness rather than promoting preventive care and keeping people healthy. This approach leads to higher healthcare costs and poorer health outcomes compared to other developed countries.

Select two underdeveloped countries and examine the key Nursing Assignment Help

Select two underdeveloped countries and examine the key determinants of health. Compare and contrast the healthcare systems, economy, and healthcare system challenges, such as access to care and health disparities. Use the Eight Factor Model to assess the strengths and weaknesses of the healthcare systems and determine the extent to

SU Strategic Planning and Business Plan Discussion Nursing Assignment Help

Ascertain the importance of strategic planning for an organization. Suggest one strategy to structure the strategic planning session for a midsize nonprofit health organization that is competing with several for-profit facilities in the area. Then determine your approach to communicate the mission, vision, and value statements for the strategic planning.

Select two underdeveloped countries and examine the key Nursing Assignment Help

Select two underdeveloped countries and examine the key determinants of health. Compare and contrast the healthcare systems, economy, and healthcare system challenges, such as access to care and health disparities. Use the Eight Factor Model to assess the strengths and weaknesses of the healthcare systems and determine the extent to

FIU Ambiguity and Doubts About Managing ASD Reflection Nursing Assignment Help

Autism Spectrum Disorder, Intellectual Disabilities, and Childhood-Onset Schizophrenia After studying Module 5: Lecture Materials & Resources, discuss the following: Reflect on your experience creating a treatment plan for a toddler, school-aged child, or adolescent with autism or an intellectual disability.  Describe the clinical situation in detail.  (Who was it, when

NUR 630 FIU Impact on Healthcare Systems and Public Health Nursing Assignment Help

Autism Spectrum Disorder, Intellectual Disabilities, or Childhood-Onset Schizophrenia In recent years, there have been reports linking autism to vaccinations. After studying Module 5: Lecture Materials & Resources, address the following in a well-written discussion post: Explain the controversy regarding vaccines as a possible cause of autism spectrum disorder. Does the